Study predicts Important role for stereotactic ablative radiotherapy in treatment of early-stage non-small cell lung cancer

Long-term study results indicate that stereotactic ablative radiotherapy for inoperable, early-stage non–small cell lung cancer provided overall survival, loco-regional, and distant disease control rates comparable to those seen with surgery, all with low toxicity.
Cancer Therapy Advisor